Annual CAPEX
$470.00 K
-$856.00 K-64.56%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual capital expenditures is currently $470.00 thousand, with the most recent change of -$856.00 thousand (-64.56%) on 31 December 2023. During the last 3 years, it has risen by +$383.00 thousand (+440.23%). LXRX annual CAPEX is now -97.62% below its all-time high of $19.77 million, reached on 31 December 2002.LXRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$307.00 K
+$57.00 K+22.80%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly capital expenditures is currently $307.00 thousand, with the most recent change of +$57.00 thousand (+22.80%) on 30 September 2024. Over the past year, it has increased by +$224.00 thousand (+269.88%). LXRX quarterly CAPEX is now -96.49% below its all-time high of $8.73 million, reached on 31 March 2002.LXRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$557.00 K
+$224.00 K+67.27%
30 September 2024
Summary:
Lexicon Pharmaceuticals TTM capital expenditures is currently $557.00 thousand, with the most recent change of +$224.00 thousand (+67.27%) on 30 September 2024. Over the past year, it has dropped by -$1.16 million (-67.54%). LXRX TTM CAPEX is now -97.48% below its all-time high of $22.11 million, reached on 30 June 2002.LXRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -64.6% | +269.9% | -67.5% |
| 3 y3 years | +440.2% | +44.1% | -55.5% |
| 5 y5 years | +394.7% | +100.0% | +420.6% |
LXRX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -64.6% | +440.2% | -75.4% | -67.5% | +440.8% | |
| 5 y | 5 years | -64.6% | +571.4% | -75.4% | -67.5% | +1587.9% | |
| alltime | all time | -97.6% | +571.4% | -96.5% | -97.5% | +1587.9% |
Lexicon Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $307.00 K(+22.8%) | $557.00 K(+67.3%) |
| June 2024 | - | $250.00 K(>+9900.0%) | $333.00 K(-29.1%) |
| Dec 2023 | $470.00 K(-64.6%) | $0.00(-100.0%) | $470.00 K(-72.6%) |
| Sept 2023 | - | $83.00 K(-40.3%) | $1.72 M(+4.8%) |
| June 2023 | - | $139.00 K(-44.0%) | $1.64 M(+9.3%) |
| Mar 2023 | - | $248.00 K(-80.1%) | $1.50 M(+13.0%) |
| Dec 2022 | $1.33 M(+8.6%) | $1.25 M(>+9900.0%) | $1.33 M(+1187.4%) |
| Sept 2022 | - | $4000.00(>+9900.0%) | $103.00 K(-67.0%) |
| June 2022 | - | $0.00(-100.0%) | $312.00 K(-75.2%) |
| Mar 2022 | - | $76.00 K(+230.4%) | $1.26 M(+3.1%) |
| Dec 2021 | $1.22 M(+1303.4%) | $23.00 K(-89.2%) | $1.22 M(-2.5%) |
| Sept 2021 | - | $213.00 K(-77.5%) | $1.25 M(+16.8%) |
| June 2021 | - | $947.00 K(+2392.1%) | $1.07 M(+757.6%) |
| Mar 2021 | - | $38.00 K(-29.6%) | $125.00 K(+43.7%) |
| Dec 2020 | $87.00 K(+24.3%) | $54.00 K(+63.6%) | $87.00 K(+163.6%) |
| Sept 2020 | - | $33.00 K(>+9900.0%) | $33.00 K(-52.9%) |
| Dec 2019 | $70.00 K(-26.3%) | $0.00(0.0%) | $70.00 K(-34.6%) |
| Sept 2019 | - | $0.00(0.0%) | $107.00 K(-2.7%) |
| June 2019 | - | $0.00(-100.0%) | $110.00 K(-12.0%) |
| Mar 2019 | - | $70.00 K(+89.2%) | $125.00 K(+31.6%) |
| Dec 2018 | $95.00 K(-58.3%) | $37.00 K(+1133.3%) | $95.00 K(+53.2%) |
| Sept 2018 | - | $3000.00(-80.0%) | $62.00 K(-48.3%) |
| June 2018 | - | $15.00 K(-62.5%) | $120.00 K(-31.8%) |
| Mar 2018 | - | $40.00 K(+900.0%) | $176.00 K(-22.8%) |
| Dec 2017 | $228.00 K(-1.3%) | $4000.00(-93.4%) | $228.00 K(-38.7%) |
| Sept 2017 | - | $61.00 K(-14.1%) | $372.00 K(+13.8%) |
| June 2017 | - | $71.00 K(-22.8%) | $327.00 K(+21.6%) |
| Mar 2017 | - | $92.00 K(-37.8%) | $269.00 K(+16.5%) |
| Dec 2016 | $231.00 K(-74.6%) | $148.00 K(+825.0%) | $231.00 K(-29.8%) |
| Sept 2016 | - | $16.00 K(+23.1%) | $329.00 K(-33.8%) |
| June 2016 | - | $13.00 K(-75.9%) | $497.00 K(-47.5%) |
| Mar 2016 | - | $54.00 K(-78.0%) | $947.00 K(+4.1%) |
| Dec 2015 | $910.00 K(+1037.5%) | $246.00 K(+33.7%) | $910.00 K(+30.4%) |
| Sept 2015 | - | $184.00 K(-60.3%) | $698.00 K(+34.0%) |
| June 2015 | - | $463.00 K(+2623.5%) | $521.00 K(+655.1%) |
| Mar 2015 | - | $17.00 K(-50.0%) | $69.00 K(-13.8%) |
| Dec 2014 | $80.00 K(-95.4%) | $34.00 K(+385.7%) | $80.00 K(-69.3%) |
| Sept 2014 | - | $7000.00(-36.4%) | $261.00 K(-50.0%) |
| June 2014 | - | $11.00 K(-60.7%) | $522.00 K(-42.6%) |
| Mar 2014 | - | $28.00 K(-87.0%) | $910.00 K(-47.1%) |
| Dec 2013 | $1.72 M(+249.8%) | $215.00 K(-19.8%) | $1.72 M(+6.3%) |
| Sept 2013 | - | $268.00 K(-32.8%) | $1.62 M(+15.6%) |
| June 2013 | - | $399.00 K(-52.4%) | $1.40 M(+27.7%) |
| Mar 2013 | - | $839.00 K(+642.5%) | $1.10 M(+123.0%) |
| Dec 2012 | $492.00 K(-59.2%) | $113.00 K(+126.0%) | $492.00 K(-16.3%) |
| Sept 2012 | - | $50.00 K(-47.4%) | $588.00 K(-18.3%) |
| June 2012 | - | $95.00 K(-59.4%) | $720.00 K(-22.8%) |
| Mar 2012 | - | $234.00 K(+12.0%) | $933.00 K(-22.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $1.21 M(+6.5%) | $209.00 K(+14.8%) | $1.21 M(-3.6%) |
| Sept 2011 | - | $182.00 K(-40.9%) | $1.25 M(-9.7%) |
| June 2011 | - | $308.00 K(-39.3%) | $1.39 M(+20.0%) |
| Mar 2011 | - | $507.00 K(+99.6%) | $1.15 M(+1.9%) |
| Dec 2010 | $1.13 M(+206.8%) | $254.00 K(-19.6%) | $1.13 M(+19.9%) |
| Sept 2010 | - | $316.00 K(+310.4%) | $944.00 K(+37.0%) |
| June 2010 | - | $77.00 K(-84.1%) | $689.00 K(-1.3%) |
| Mar 2010 | - | $485.00 K(+634.8%) | $698.00 K(+89.2%) |
| Dec 2009 | $369.00 K(-83.1%) | $66.00 K(+8.2%) | $369.00 K(-54.9%) |
| Sept 2009 | - | $61.00 K(-29.1%) | $818.00 K(-20.3%) |
| June 2009 | - | $86.00 K(-44.9%) | $1.03 M(-29.9%) |
| Mar 2009 | - | $156.00 K(-69.7%) | $1.46 M(-33.1%) |
| Dec 2008 | $2.19 M(+15.1%) | $515.00 K(+91.4%) | $2.19 M(-3.9%) |
| Sept 2008 | - | $269.00 K(-48.7%) | $2.27 M(-3.8%) |
| June 2008 | - | $524.00 K(-40.4%) | $2.37 M(-3.9%) |
| Mar 2008 | - | $879.00 K(+45.8%) | $2.46 M(+29.5%) |
| Dec 2007 | $1.90 M(-46.9%) | $603.00 K(+68.0%) | $1.90 M(+10.9%) |
| Sept 2007 | - | $359.00 K(-42.1%) | $1.71 M(-21.3%) |
| June 2007 | - | $620.00 K(+95.0%) | $2.18 M(-19.6%) |
| Mar 2007 | - | $318.00 K(-23.6%) | $2.71 M(-24.4%) |
| Dec 2006 | $3.58 M(-68.3%) | $416.00 K(-49.4%) | $3.58 M(-29.2%) |
| Sept 2006 | - | $822.00 K(-28.5%) | $5.05 M(-26.1%) |
| June 2006 | - | $1.15 M(-3.6%) | $6.84 M(-26.7%) |
| Mar 2006 | - | $1.19 M(-36.9%) | $9.34 M(-17.2%) |
| Dec 2005 | $11.28 M(-4.5%) | $1.89 M(-27.6%) | $11.28 M(-21.9%) |
| Sept 2005 | - | $2.61 M(-28.4%) | $14.45 M(-3.8%) |
| June 2005 | - | $3.65 M(+16.4%) | $15.01 M(+10.0%) |
| Mar 2005 | - | $3.13 M(-38.1%) | $13.65 M(+15.6%) |
| Dec 2004 | $11.81 M(+144.8%) | $5.06 M(+59.4%) | $11.81 M(+50.8%) |
| Sept 2004 | - | $3.17 M(+38.7%) | $7.83 M(+24.0%) |
| June 2004 | - | $2.29 M(+77.2%) | $6.32 M(+16.4%) |
| Mar 2004 | - | $1.29 M(+19.5%) | $5.43 M(+12.5%) |
| Dec 2003 | $4.82 M(-75.6%) | $1.08 M(-34.8%) | $4.82 M(-37.1%) |
| Sept 2003 | - | $1.66 M(+18.5%) | $7.67 M(-13.1%) |
| June 2003 | - | $1.40 M(+102.9%) | $8.82 M(-24.7%) |
| Mar 2003 | - | $689.00 K(-82.4%) | $11.72 M(-40.7%) |
| Dec 2002 | $19.77 M(+46.7%) | $3.92 M(+39.4%) | $19.77 M(-5.4%) |
| Sept 2002 | - | $2.81 M(-34.5%) | $20.90 M(-5.4%) |
| June 2002 | - | $4.29 M(-50.8%) | $22.11 M(+12.2%) |
| Mar 2002 | - | $8.73 M(+72.7%) | $19.71 M(+46.3%) |
| Dec 2001 | $13.47 M(+74.7%) | $5.06 M(+25.8%) | $13.47 M(+12.7%) |
| Sept 2001 | - | $4.02 M(+111.6%) | $11.96 M(+11.2%) |
| June 2001 | - | $1.90 M(-23.9%) | $10.75 M(+10.2%) |
| Mar 2001 | - | $2.50 M(-29.6%) | $9.75 M(+26.5%) |
| Dec 2000 | $7.71 M(+88.0%) | $3.54 M(+25.9%) | $7.71 M(+85.1%) |
| Sept 2000 | - | $2.81 M(+212.9%) | $4.17 M(+208.4%) |
| June 2000 | - | $899.70 K(+99.5%) | $1.35 M(+199.5%) |
| Mar 2000 | - | $450.90 K | $450.90 K |
| Dec 1999 | $4.10 M | - | - |
FAQ
- What is Lexicon Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual CAPEX year-on-year change?
- What is Lexicon Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Lexicon Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals TTM CAPEX year-on-year change?
What is Lexicon Pharmaceuticals annual capital expenditures?
The current annual CAPEX of LXRX is $470.00 K
What is the all time high annual CAPEX for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual capital expenditures is $19.77 M
What is Lexicon Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, LXRX annual capital expenditures has changed by -$856.00 K (-64.56%)
What is Lexicon Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of LXRX is $307.00 K
What is the all time high quarterly CAPEX for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly capital expenditures is $8.73 M
What is Lexicon Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, LXRX quarterly capital expenditures has changed by +$224.00 K (+269.88%)
What is Lexicon Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of LXRX is $557.00 K
What is the all time high TTM CAPEX for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high TTM capital expenditures is $22.11 M
What is Lexicon Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, LXRX TTM capital expenditures has changed by -$1.16 M (-67.54%)